oxybutynin has been researched along with physostigmine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kontani, H; Nakagawa, M; Sakai, T; Takeno, S | 1 |
| Cho, Y; Ha, YC; Hur, GH; Kim, WS | 1 |
| Banerjee, S; Chattopadhyay, P; Ghosh, A; Kaity, S; Veer, V | 1 |
| Banerjee, S; Chattopadhyay, P; Ghosh, A; Pathak, MP; Singh, S; Veer, V | 1 |
| Banerjee, S; Chattopadhyay, P; Ghosh, A; Gogoi, J; Pathak, MP; Veer, V | 1 |
| Banerjee, S; Bhatnagar, A; Chattopadhyay, P; Ghosh, A; Veer, V | 1 |
| Fratta, KA; Ginder, M; Haggerty, DA | 1 |
1 review(s) available for oxybutynin and physostigmine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for oxybutynin and physostigmine
| Article | Year |
|---|---|
Evaluation of drugs for treatment of urinary bladder dysfunction in conscious rats with intact pelvic nerve and after resection of the left pelvic nerve.
Topics: Animals; Atropine; Butylamines; Decerebrate State; Drug Evaluation; Male; Mandelic Acids; Nifedipine; Parasympatholytics; Physostigmine; Rats; Rats, Inbred Strains; Urinary Bladder; Urinary Bladder Diseases | 1990 |
Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
Topics: Acetylcholinesterase; Animals; Antidotes; Atropine; Brain; Chemical Warfare Agents; Cholinesterase Inhibitors; Cholinesterase Reactivators; Lethal Dose 50; Macaca mulatta; Male; Muscarinic Antagonists; Oximes; Physostigmine; Poisoning; Procyclidine; Pyridinium Compounds; Soman; Transdermal Patch | 2012 |
Development and validation of a reverse phase liquid chromatography method for the simultaneous quantification of eserine and pralidoxime chloride in drugs-in-adhesive matrix type transdermal patches.
Topics: Adhesives; Chromatography, Reverse-Phase; Hydrogen-Ion Concentration; Physostigmine; Pralidoxime Compounds; Transdermal Patch | 2013 |
Acute dermal irritation, sensitization, and acute toxicity studies of a transdermal patch for prophylaxis against ({+/-}) anatoxin-a poisoning.
Topics: Administration, Cutaneous; Animals; Cyanobacteria Toxins; Drug Evaluation, Preclinical; Female; Guidelines as Topic; Guinea Pigs; Male; Physostigmine; Pralidoxime Compounds; Rabbits; Rats; Skin; Skin Tests; Toxicity Tests, Acute; Transdermal Patch; Tropanes | 2013 |
Protection by a transdermal patch containing eserine and pralidoxime chloride for prophylaxis against (±)-Anatoxin A poisoning in rats.
Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Arrhythmias, Cardiac; Brain; Cyanobacteria Toxins; Male; Neuroprotective Agents; Physostigmine; Pralidoxime Compounds; Rats, Wistar; Seizures; Skin; Transdermal Patch; Tropanes | 2014 |
Pharmacokinetic and biodistribution study of eserine and pralidoxime chloride in rabbits following a single application of a transdermal patch.
Topics: Administration, Cutaneous; Animals; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Physostigmine; Pralidoxime Compounds; Rabbits; Tissue Distribution; Transdermal Patch | 2016 |
Oral and Transdermal Rivastigmine for the Treatment of Anticholinergic Delirium: A Case Report.
Topics: Acetylcholinesterase; Anticholinergic Syndrome; Antidotes; Cholinergic Antagonists; Cholinesterase Inhibitors; Delirium; Female; Humans; Middle Aged; Physostigmine; Rivastigmine; Transdermal Patch | 2023 |